Now enjoying a period of relative political stability and with a swathe of economic reforms in the pipeline, Egypt is once more becoming one of the most favourable investment destinations in its region.

Nowhere is this trend more apparent than in healthcare. With the launch of the Universal Healthcare Act, which aims to provide health coverage to all of Egypt’s 98 million inhabitants, as well as various national campaigns aimed at eradicating diseases such as Hepatitis C, healthcare and life sciences firms are increasingly cognizant of the abundant opportunities that Egypt has to offer.

Topics covered in this wide-ranging new report include the changing mindset of the Egyptian state towards healthcare, the country’s evolving healthcare needs, the numerous operational obstacles that still face pharmaceutical companies doing business in Egypt, the innovative strategies being utilised to overcome them, Egyptian firms’ manufacturing prowess, and Egypt’s potential to be a pharmaceutical export hub for Africa and beyond.